Biological foundation for periodontitis as a potential risk factor for atherosclerosis

Journal of Periodontal Research

Volumn 40, Issue 1, 2005, Pages 87-95

  Chun, Yong Hee P ^a   Chun, Kyoung Ryul J ^b   Olguin, De'Avlin ^a   Wang, Hom Lay ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b DEPARTMENT OF CARDIOLOGY   (Germany)

Author keywords

Atherosclerosis; Bacteremia; Cardiovascular disease; Periodontal disease; Porphyromonas gingivalis

Indexed keywords

ANTIBIOTIC AGENT;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ALVEOLAR BONE; ANTIBIOTIC THERAPY; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOLOGY; BLOOD CLOTTING; CAPNOCYTOPHAGA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ISOLATION; CHLAMYDIA; CIRCULATION; CLINICAL FEATURE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DATA BASE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; EIKENELLA CORRODENS; ENDOTHELIUM; ENVIRONMENTAL FACTOR; EXPERIMENT; FOAM CELL; FOLLOW UP; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HEALTH; HELICOBACTER; HEMOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; IMAGE ANALYSIS; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; OSTEOLYSIS; PATHOGENESIS; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVENTIVE DENTISTRY; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; SYSTEMIC DISEASE; THROMBOEMBOLISM; THROMBOSIS;

EID: 13244267130     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2004.00771.x     Document Type: Short Survey

References (123)

1. Kannel WB, Castelli WP, McNamara PM. Serum lipid fractions and risk of coronary heart disease. The Framingham study. Minn Med 1969;52:1225-1230.
2. Kahn HA, Dawber TR. The development of coronary heart disease in relation to sequential biennial measures of cholesterol in the Framingham study. J Chronic Dis 1966;19:611-620.
3. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
4. Yu H, Rifai N. High-sensitive C-reactive protein and atherosclerosis: from theory to therapy. Clin Biochem 2000;33:601-610.
5. Lopatin DE, Jaramillo E, Edwards CA, Van Poperin N, Combs A, Shelburne CE. Cellular localization of a Hsp90 homologue in Porphyromonas gingivalis. FEMS Microbiol Lett 1999;181:9-16.
6. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM. Homocysteine and ischemic heart disease. Results of a prospective study with implications regarding prevention. Arch Intern Med 1998;158:862-867.
7. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-505.
8. Meade TW, Mellows S, Brozovic M et al. Haemostatic function and ischemic heart disease: Principle results of the Northwick Park Heart Study. Lancet 1986;2:533-537.
9. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: The Framingham study. JAMA 1987;258:1183-1186.
10. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.
11. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-428.
12. Ridker PM. Novel risk factors and markers for coronary disease. Adv Intern Med 2000;45:391-418.
13. Xu Q, Willeit J, Marosi M et al. Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis. Lancet 1993;341:255-259.
14. Xu Q, Kiechl S, Mayr M et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 1999;100:1169-1174.
15. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. Meta-analyses of prospective studies. JAMA 1998;279:1477-1482.
16. Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999;138:S534-S536.
17. Forng RY, Champagne C, Simpson W, Genco CA. Environmental cues and gene expression in Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. Oral Dis 2000;6:351-365.
18. Folsom AR, Nieto FJ, Sorlie P, Chambless LE, Graham DY. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis risk in communities (ARIC) study investigators. Circulation 1998;98:845-850.
19. Strachan DP, Mendall MA, Carrington D et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the Caerphilly prospective heart disease study. Circulation 1998;98:1286-1290.
20. Ridker PM, Danesh J, Youngman L et al. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men. Ann Intern Med 2001;135:184-188.
21. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ 1997;315:1199-1201.
22. Blasi F, Ranzi ML, Erba M et al. No evidence for the presence of Helicobacter pylori in atherosclerotic plaques in abdominal aortic aneurysm specimens. Atherosclerosis 1996;126:339-340.
23. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-436.
24. Mattila KJ, Nieminen MS, Valtonen V et al. Association between dental health and acute myocardial infarction. BMJ 1989;298:779-782.
25. Genco R, Chadda S, Grossi S et al. Periodontal disease is a predictor of cardiovascular disease in native Americans. J Dent Res 1997;76:408.
26. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Pre-existing cardiovascular disease and periodontitis: a follow-up study. J Dent Res 2002;81:186-191.
27. Janket S-J, Baird AE, Chuang S-K, Jones JA. Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:559-569.
28. Grossi SG, Zambon JJ, Ho AW et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994;65:260-267.
29. Dzink JL, Socransky SS, Haffajee AD. The predominant cultiviable microbiota of active and inactive lesions of destructive periodontal diseases. J Clin Periodontol 1988;15:316-323.
30. Loesche WJ, Syed SA, Schmidt E, Morrison EC. Bacterial profiles of subgingival plaques in periodontitis. J Periodontol 1985;56:447-456.
31. Duncan MJ, Nakao S, Skobe Z, Xie H. Interactions of Porphyromonas gingivalis with epithelial cells. Infect Immun 1993;61:2260-2265.
32. Lamont RJ, Oda D, Persson RE, Persson GR. Interaction of Porphyromonas gingivalis with gingival epithelial cells maintained in culture. Oral Microbiol Immunol 1992;7:364-367.
33. Saglie FR, Marfany A, Camargo P. Intragingival occurrence of Actinobacillus actinomycetemconitans and Bacteroides gingivalis in active destructive periodontal lesions. J Periodontol 1988;59:259-265.
34. Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 1998;66:5337-5343.
35. Khlgatian M, Nassar H, Chou H-H, Gibson FC, Genco CA. Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells. Infect Immun 2002;70:257-267.
36. Lopatin DE, Blackburn E. Avidity and titer of immune-globulin G subclasses to Porphyromonas gingivalis in adult periodontitis patients. Oral Microbiol Immunol 1992;7:332-337.
37. Mahanonda R, Seymour GJ, Powell LW, Good MF, Halliday JW. Effect of initial treatment of chronic inflammatory periodontal disease on the frequency of peripheral blood T-lymphocytes specific to periodontopathic bacteria. Oral Microbiol Immunol 1991;6:221-227.
38. Miller WD. The human mouth as a focus of infection. Dental Cosmos 1891;33:689-713.
39. Hunter W. Oral sepsis as a cause of disease. Br Med J 1900;1:215-216.
40. Silver JG, Martin AW, McBride BC. Experimental transient bacteremias in human subjects with varying degrees of plaque accumulation and gingival inflammation. J Clin Periodontol 1977;4:92-99.
41. Heimdahl A, Hall G, Hedberg M et al. Detection and quantification by lysis-filtration of bacteremia after different oral surgical procedures. J Clin Microbiol 1990;28:2205-2209.
42. Daly CG, Mitchell DH, Highfield JE, Grossberg DE, Stewart DL. Bacteremia due to periodontal probing: a clinical and microbiological investigation. J Periodontol 2001;72:210-214.
43. Geerts SO, Nys M, De MP et al. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol 2002;73:73-78.
44. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000;71:1554-1560.
45. Libby P, Egan D, Skarlattos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997;96:4095-4103.
46. Hirose K, Isogai E, Ueda I. Porphyromonas gingivalis fimbriae induce adhesion of monocytic cell line U937 to endothelial cells. Microbiol Immunol 2000;44:17-22.
47. Dorn BR, Dunn WAJ, Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens. Infect Immun 1999;67:5792-5798.
48. Bhagat K, Moss R, Collier J, Vallence P. Endothelial 'stunning' following a brief exposure to endotoxin: a mechanism to link infection and infarction? Cardiovasc Res 1996;32:822-829.
49. Amar S, Gokce N, Morgan S, Loukedeli M, Van Dyke TE, Vita JA. Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol 2003;23:1245-1249.
50. Breslow JL. Mouse models of atherosclerosis. Science 1996;272:685-688.
51. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992;258:468-471.
52. Plump AS, Smith JD, Hayek T et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343-353.
53. Zhang SH, Reddick RL, Burkey B, Maeda N. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 1994;94:937-945.
54. Li L, Messas E, Batista EL, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002;105:861-867.
55. Lalla E, Lamster IB, Hofmann MA et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003;23:1405-1411.
56. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
57. De Nardin E. The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease. Ann Periodontol 2001;6:30-40.
58. Glass CK, Witzum JL. Atherosclerosis: the road ahead. Cell 2001;104:503-516.
59. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
60. Funk JL, Feingold KR, Moser AH, Grunfeld C. Lipopolysaccharide stimulation of RAW 264.7 macrophages induce lipid accumulation and foam cell formation. Atherosclerosis 1993;98:67-82.
61. Shapira L, Warbington M, Van Dyke TE. TNF alpha and IL-1 beta in serum of LJP patients with normal and defective neutrophil chemotaxis. J Periodont Res 1994;29:371-373.
62. Beck J, Garcia R, Heiss G, Voskonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996;67:1123-1137.
63. Gosling J, Slaymaker S, Gu L et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 1999;103:773-778.
64. Kang I-C, Kuramitsu HK. Induction of monocyte chemoattractant protein-1 by Porphyromonas gingivalis in human endothelial cells. FEMS Immunol Med Microbiol 2002;34:311-317.
65. Qi M, Miyakawa H, Kuramitsu HK. Porphyromonas gingivalis induces murine macrophage foam cell formation. Microb Pathog 2003;35:259-267.
66. Kuramitsu HK, Kang IC, Qi M. Interactions of Porphyromonas gingivalis with host cells: implications for cardiovascular disease. J Periodontol 2003;74:85-89.
67. Offenbacher S, Madianos PN, Champagne C et al. Periodontitis- atherosclerosis syndrome: an expanded model of pathogenesis. J Periodont Res 1999;34:346-352.
68. Jain A, Batista EL, Serhan C, Stahl GL, Van Dyke TE. Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun 2003;71:6012-6018.
69. Xu Q, Kleindienst R, Schett G et al. Regression of arteriosclerotic lesions induced by immunization with heat shock protein 65-containing material in normocholesterolemic, but not hypercholesterolemic rabbits. Atherosclerosis 1996;123:145-155.
70. Wick G, Kleindienst R, Schett G, Amberger A, Xu Q. Role of heat shock protein 65/60 in the pathogenesis of atherosclerosis. Int Arch Allergy Immunol 1995;107:130-131.
71. Maeda H, Miyamoto M, Hongyo H, Nagai A, Kurihara H, Muryama Y. Heat shock protein 60 (GroEL) from Porphyromonas gingivalis: molecular cloning and sequence analysis of its gene and purification of the recombinant protein. FEMS Microbiol Lett 1994;124:121-122.
72. Lopatin DE, Shelburne CE, Van Poperin N, Kowalski CJ, Bagramian RA. Humoral immunity to stress proteins and periodontal disease. J Periodontol 1999;70:1185-1193.
73. Xu Q, Dietrich H, Steiner HJ et al. Induction of artherosclerosis in normocholesterolemic rabbits by immunization with heat-shock protein 65. Arterioscler Thromb 1992;12:789-799.
74. Mori Y, Kitamura H, Song QH, Kobayashi T, Uemura S, Oyong JC. A new murine model for atherosclerosis with inflammation in the periodontal tissue induced by immunization with heat shock protein. Hypertens Res 2000;23:475-481.
75. Choi J, Chung S-W, Kim S-J, Kim S-J. Establishment of Porphyromonas gingivalis-specific T cell lines from atherosclerosis patients. Oral Microbiol Immunol 2001;16:316-318.
76. Choi J-I, Chung S-W, Kang H-S, Rhim BY, Kim S-J, Kim S-J. Establishment of Porphyromonas gingivalis heat-shock-protein-specific T-cell lines from atherosclerosis patients. J Dent Res 2002;81:344-348.
77. Chung S-W, Kang H-S, Park H-R, Kim S-J, Kim S-J, Choi J-I. Immune responses to heat shock protein in Porphyromonas gingivalis infected periodontitis and atherosclerosis patients. J Periodont Res 2003;38:388-393.
78. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
79. Koenig W, Sund M, Frohlich M et al. C-reactive protein, a marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trend and Determinants in Cardiovascular Disease) Augsburg cohort study, 1984-92. Circulation 1999;99:237-242.
80. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple risk factor intervention trial. Am J Epidemiol 1996;144:537-547.
81. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843.
82. Zhang YX, Cliff WJ, Schoefl GI, Higgins G. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis 1999;145:375.
83. Pepys MB, Rowe IF, Baltz ML. C-reactive protein: binding to lipids and lipoproteins. Int Rev Exp Pathol 1985;27:83-111.
84. Folsom AR, Pankow JS, Tracy RP et al. The investigator of the NHBLI family heart study. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001;15:112-117.
85. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001;103:1194-1197.
86. Seifert PS, Hugo F, Hansson GK, Bhakdi S. Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. Lab Invest 1989;60:747-754.
87. Lagrand WK, Niessen HWM, Wolbink G-J et al. C-reactive protein colocalizes with complement in human hearts during myocardial infarction. Circulation 1997;95:97-103.
88. Torzewski J, Torzewski M, Bowyer DE et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998;18:1386-1392.
89. Reynolds GD, Vance RP. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med 1987;111:265-269.
90. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978.
91. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactive patients with coronary artery disease. Circulation 2000;102:1000-1006.
92. Sitzer M, Markus HS, Mendall MA, Liehr R, Knorr U, Steinmetz H. C-reactive protein and carotid intimal medial thickness in a community population. J Cardiovasc Risk 2002;9:97-103.
93. Danesh J, Wheeler JG, Hirschfield GM et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-1397.
94. Ebersole JL, Machen RL, Steffen ML, Willmann DE. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 1997;107:347-352.
95. Fredriksson MI, Figueredo CMS, Gustafsson A, Bergström KG, Asman BE. Effect of periodontitis and smoking on blood leukocytes and acute-phase proteins. J Periodontol 1999;70:1355-1360.
96. Loos BG, Craandijk J, Hoek FJ, Wertheim-van-Dillen PM, van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000;71:1528-1534.
97. Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos CT. Examination of the relation between periodontal health status and cardiovascular risk factors: serum total high density lipoprotein cholesterol, C-reactive protein and plasma fibrinogen. Am J Epidemidol 2000;151:273-282.
98. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 2000;79:49-57.
99. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221-1227.
100. Glurich I, Grossi S, Albini B et al. Systemic inflammation in cardiovascular and periodontal disease: Comparative study. Clin Diagn Lab Immunol 2002;9:425-432.
101. Ghezzi E, Ship JA. Systemic diseases and their treatments in the elderly: impact on oral health. J Public Health Dent 2000;60:289-296.
102. Joshipura K, Pitiphat W, Douglass CW. Validation of self-reported periodontal measures among health professionals. J Public Health Dent 2002;62:115-121.
103. Wakai K, Kawamura T, Umemura O et al. Association of medical status and physical with periodontal disease. J Clin Periodontol 1999;26:664-672.
104. Craig RG, Yip JK, So MK, Boylan RJ, Socranscy SS, Haffajee AD. Relationship of destructive periodontal disease to the acute-phase response. J Periodontol 2003;74:1007-1016.
105. Mattila K, Vesanen M, Valtonen V et al. Effect of treating periodontitis on C-reactive protein levels: a pilot study. BMC Infect Dis 2002;2:30-33.
106. McGill HCJ. Fatty streaks in the aorta and coronary arteries and aorta. Lab Invest 1968;18:560-564.
107. Lowe GDO. Etiopathogenesis of cardiovascular disease: hemostasis, thrombosis, and vascular medicine. Ann Periodontol 1998;3:121-126.
108. Herzberg MC, Brintzenhofe KL, Clawson CC. Aggregation of human platelets and adhesion of Streptococcus sanguis. Infect Immun 1983;39:1457-1469.
109. Herzberg MC, Meyer MW. Effects of oral flora on platelets: Possible consequences in cardiovascular disease. J Periodontol 1996;67:1138-1142.
110. Sharma A, Novak EK, Sojar HT, Swank RT, Kuramitsu HK, Genco RJ. Porphyromonas gingivalis platelet aggregation activity: outer membrane vesicles are potent activators of murine platelets. Oral Microbiol Immunol 2000;15:393-396.
111. Kuramitsu HK, Qi M, Kang I-C, Chen W. Role for bacteria in cardiovascular disease. Ann Periodontol 2001;6:41-47.
112. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SKJ. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
113. Chambless LE, Heiss G, Folsom AR et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-93. Am J Epidemiol 1997;146:483-494.
114. Beck JD, Elter JR, Heiss G, Couper D, Mauriello SM, Offenbacher S. Relationship of periodontal disease to carotid artery intima-media wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 2001;21:1816-1822.
115. Desvarieux M, Demmer RT, Rundek T et al. Relationship between periodontal disease, tooth loss, and carotid artery plaque. The oral infections and vascular disease epidemiology study (INVEST). Stroke 2003;34:2120-2125.
116. Kiechl S, Egger G, Mayr M et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001;103:1064-1070.
117. Espinola-Klein C, Rupprecht HJ, Blankenberg S et al. Impact of infectious burden on extend and long-term prognosis of atherosclerosis. Circulation 2002;105:15-21.
118. Zhu J, Quyyumi AA, Norman JE et al. Effects of total pathogen burden on coronary artery disease risk and c-reactive protein level. Am J Cardiol 2000;85:140-146.
119. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 2000;20:1417-1420.
120. Frisk F, Hakeberg M, Ahlqwist M, Bengtsson C. Endodontic variables and coronary heart disease. Acta Odontol Scand 2003;61:257-262.
121. Joshipura KJ, Douglass CW, Willett WC. Possible explanations for the tooth loss and cardiovascular disease relationship. Ann Periodontol 1998;3:175-183.
122. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Examining the link between coronary heart disease and the elimination of chronic dental infections. J Am Dent Assoc 2001;132:883-889.
123. Cutler CW, Iacopino AM. Periodontal disease: links with serum lipid/triglyceride levels? Review and new data. J Int Acad Periodontol 2003;5:47-51.